Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclophosphamide in ME/CFS
NCT02444091Phase 2Completed
- Sponsor
- Haukeland University Hospital
- Start
- Mar 2015
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), sponsored by Haukeland University Hospital. Started Mar 2015; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
Beyond the preview
Go deeper on NCT02444091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02444091.